Biologic Therapeutics Market Growth by Application, Product, and Geography - Forecast and Analysis 2023-2027
| Published: Mar 2023 | Pages: 174 | SKU: IRTNTR44341 |
Biologic Therapeutics Market By Application: Cancer, Infectious Diseases & Product: Antibody Therapeutics, Vaccines, Cell Therapy
The Global Biologic Therapeutics Market size is estimated to grow at a CAGR of 11.34% between 2022 and 2027. The size of the market is forecast to increase by USD 286.12 billion. The growth of the biologic therapeutics drugs market depends on several factors, including the introduction of biosimilars, increasing incidence of chronic diseases and immunological disorders, and patent expiry of major biologics.
This biologic therapeutics market research report extensively covers market segmentation by application (cancer, infectious diseases, autoimmune diseases, and others), product (antibody therapeutics, vaccines, cell therapy, gene therapy, and others), and geography (North America, Europe, Asia, and Rest of World (ROW)). It also includes an in-depth analysis of drivers, trends, and challenges.
What will be the Size of the Biologic Therapeutics Market During the Forecast Period?
To learn more about this report, Request Free Sample
Biologic Therapeutics Market: Key Drivers, Trends, Challenges, and Customer Landscape
Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Key Biologic Therapeutics Market Driver
The introduction of biosimilars is notably driving the biologic therapeutics market growth. A biosimilar is a biological product that closely resembles an already approved biopharmaceutical without clinically meaningful differences in safety, purity, and efficacy. They have been developed using different cell lines, manufacturing processes, or formulations, but have the same mechanism of action as the original biologic. The introduction of biosimilars has the potential to drive the biologic therapeutics market through increased competition and reduced treatment costs. Biosimilars have the potential to give patients who otherwise could not have increased access to life-saving medicines. Biosimilars can also help reduce medical costs.
This is especially important as healthcare costs continue to rise. A biosimilar is considered a successor to a biopharmaceutical when the biopharmaceutical is nearing its expiration date. The introduction of biosimilars is the latest trend in the pharmaceutical market not only to replace off-patent biologics but also to help reduce healthcare costs. Therefore, the availability of biosimilars will drive the growth of the global biologic therapeutics drugs market during the forecast period.
Significant Biologic Therapeutics Market Trends
The strong R&D pipeline is a key trend influencing the biologic therapeutics market growth. The effectiveness of biologics in treating serious infections, malignancies, immune disorders, and hormonal disorders encourages manufacturers to invest in research and development for the development of biologics. For example, monoclonal antibodies are one of the fastest-growing areas of biologic therapy. To date, 153 monoclonal antibodies have been approved or are under investigation in the EU and US for various indications. Similarly, when biologics are used as vaccines or therapeutic proteins, a pipeline of vendors such as AbbVie and Amgen are investigating biologics, and many research institutes are also working with the industry to develop new biologics. Therefore, therapeutic vaccine research and development is expected to drive the growth of the global biologic therapeutics drugs market during the forecast period.
Also, biologics are products made from living organisms, as opposed to chemically synthesized pharmaceuticals. Biologics are made by recombinant deoxyribonucleic acid (DNA) technology and have fewer side effects compared to chemical agents. In addition, one of the greatest advantages of biologics is their ability to target specific areas of the body therapeutically. Similarly, other biologics, including vaccines, are well absorbed by the body and have therapeutic effects in specific areas of the body. Therefore, targeted therapeutics are also expected to drive the growth of the global biologics market over the forecast period.
Major Biologic Therapeutics Market Challenge
The high cost of biologics is challenging the biologic therapeutics market growth. Biologics can be used to treat many types of malignancies, hormonal imbalances, and autoimmune diseases, but they are expensive and out of reach for the economically disadvantaged. Total manufacturing costs, including those associated with clinical trials associated with biologics, contribute to vendors' high-cost offerings for these products. The evolution of biological molecules requires another organism. While the production of bacteria is less expensive, the production of therapeutics such as monoclonal antibodies and vaccines is expensive due to the need to handle animals. Animal immunization and other procedures related to antibody and vaccine production increase the cost of this product.
The use of animals for production also requires government approval and the establishment of facilities to house the animals. This increases the overall cost of producing biologics. Due to the high price of biologic therapy, many patients are unable to access this effective treatment, which will remain a major challenge for the global biologic therapeutics drugs market during the forecast period.
Key Biologic Therapeutics Market Customer Landscape
The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Biologic Therapeutics Market Customer Landscape
Who are the Major Biologic Therapeutics Market Vendors?
Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the biologics market.
AbbVie Inc: The company manufactures, conducts research and development, commercializes, and sells innovative medicines and therapies in order to achieve long-term strategic goals.
The report also includes detailed analyses of the competitive landscape of the market and information about 15 market vendors, including:
- Amgen Inc.
- Apogenix AG
- AstraZeneca Plc
- Aurobindo Pharma Ltd.
- Baxter International Inc.
- Biocon Ltd.
- BioMarin Pharmaceutical Inc.
- Celltrion Healthcare Co. Ltd.
- Eli Lilly and Co.
- GangaGen Biotechnologies Pvt Ltd.
- GlaxoSmithKline Plc
- Johnson and Johnson Services Inc.
- Merck and Co. Inc.
- Novartis AG
- Pfizer Inc.
Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.
What is the Fastest-Growing Segments in the Biologic Therapeutics Market?
The biologics market share growth by the cancer segment will be significant during the forecast period. Cancer cells are cells that have lost the property of contact inhibition and continue to actively divide, often resulting in clumps of cells called tumors. In oncology, biologics are used together with chemotherapeutic agents to target only cancer cells. In contrast, chemotherapeutic agents act on cancer cells and normal cells in the body, thereby producing side effects including hair loss, nausea, and fatigue. The use of biologics in the field of oncology is expected to overtake chemotherapy as the biomolecular aspects of cancer become more defined. Hence, it is expected to drive the growth of the global biologic therapeutics market during the forecast period.
Get a glance at the market contribution of various segments View the PDF Sample
The cancer segment was valued at USD 122.20 billion in 2017 and continued to grow until 2021. The antibody therapeutics segment is the largest segment in the global biologic therapeutics market. Due to their high specificity, antibody therapeutics have some side effects. As a result, antibody therapies have become a major class of new drugs being developed in recent years. Over the past five years, antibodies have become the best-selling drugs in the pharmaceutical industry. Monoclonal antibodies are one of the best-selling biologics and have even been called the future of medicine. Such factors are expected to drive the growth of the global biologic therapeutics market during the forecast period.
Which are the Key Regions for the Biologic Therapeutics Market?
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 57% to the growth of the global biologics market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
North America is the leader in the global biologic therapeutics market. The dominance of this region is due to several factors. The United States is home to major companies such as AbbVie, Eli Lilly, Merck, Pfizer, and Amgen. These vendors offer a range of highly differentiated products that have become well-received by both physicians and patients. One of the reasons behind the market growth in America is the increase in chronic diseases. The increasing prevalence of major health disorders is primarily due to lifestyle changes and increased alcohol and tobacco use in the United States. However, only modest market growth is expected due to the patent expiry of key biologics on the market.
In 2020, the COVID-19 pandemic had a significant impact on the biologic therapeutics market. Biologics, macromolecular pharmaceuticals made using living cells, are an important part of the pharmaceutical industry and are used to treat a variety of diseases, including COVID-19. The COVID-19 pandemic has significantly increased the demand for biological therapies to treat COVID-19 patients. Several of North America's leading biotech companies, including Eli Lilly and Pfizer, are developing and commercializing COVID-19 treatments. However, the pandemic has also brought challenges to the North American bioindustry. Such factors are anticipated to drive the growth of the biologic therapeutics drugs market during the forecast period.
Segment Overview
The biologic therapeutics market research report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
- Application Outlook (USD Billion, 2017 - 2027)
- Cancer
- Infectious diseases
- Autoimmune diseases
- Others
- Product Outlook (USD Billion, 2017 - 2027)
- Antibody therapeutics
- Vaccines
- Cell therapy
- Gene therapy
- Others
- Region Outlook (USD Billion, 2017 - 2027)
- North America
- The U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Rest of Europe
- Asia
- China
- India
- Rest of the World(ROW)
- North America
|
Biologic Therapeutics Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
174 |
|
Base year |
2022 |
|
Historic period |
2017-2021 |
|
Forecast period |
2023-2027 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 11.34% |
|
Market growth 2023-2027 |
USD 286.12 billion |
|
Market structure |
Fragmented |
|
YoY growth 2022-2023(%) |
10.6 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 57% |
|
Key countries |
US, Germany, France, China, and Japan |
|
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
AbbVie Inc., Amgen Inc., Apogenix AG, AstraZeneca Plc, Aurobindo Pharma Ltd., Baxter International Inc., Biocon Ltd., BioMarin Pharmaceutical Inc., Celltrion Healthcare Co. Ltd., Eli Lilly and Co., GangaGen Biotechnologies Pvt Ltd., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Merck and Co. Inc., Novartis AG, Pfizer Inc., Precision Biologics Inc., Samsung Electronics Co. Ltd., Sanofi SA, and Tubulis GmbH |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
What are the Key Data Covered in this Biologic Therapeutics Market Research Report?
- CAGR of the biologic therapeutics drugs market during the forecast period
- Detailed information on factors that will drive the growth of the biologics market between 2023 and 2027
- Precise estimation of the size of the biologic therapeutics market size and its contribution of the market in focus to the parent market
- Accurate predictions about upcoming trends and changes in consumer behavior
- Growth of the market industry across North America, Europe, Asia, and Rest of World (ROW)
- Thorough analysis of the market’s competitive landscape and detailed information about vendors
- Comprehensive analysis of factors that will challenge the growth of biologic therapeutics market vendors
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 13: Market segments
- 3.3 Market size 2022
- 3.4 Market outlook: Forecast for 2022-2027
- Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
- Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
- 4.1 Global biologic therapeutics market 2017 - 2021
- Exhibit 18: Historic Market Size – Data Table on Global biologic therapeutics market 2017 - 2021 ($ billion)
- 4.2 Application Segment Analysis 2017 - 2021
- Exhibit 19: Historic Market Size – Application Segment 2017 - 2021 ($ billion)
- 4.3 Product Segment Analysis 2017 - 2021
- Exhibit 20: Historic Market Size – Product Segment 2017 - 2021 ($ billion)
- 4.4 Geography Segment Analysis 2017 - 2021
- Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ billion)
- 4.5 Country Segment Analysis 2017 - 2021
- Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ billion)
5 Five Forces Analysis
- 5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
- 5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
- 5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
- 5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
- 5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
- 5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
- 5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Application
- 6.1 Market segments
- Exhibit 30: Chart on Application - Market share 2022-2027 (%)
- Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
- 6.2 Comparison by Application
- Exhibit 32: Chart on Comparison by Application
- Exhibit 33: Data Table on Comparison by Application
- 6.3 Cancer - Market size and forecast 2022-2027
- Exhibit 34: Chart on Cancer - Market size and forecast 2022-2027 ($ billion)
- Exhibit 35: Data Table on Cancer - Market size and forecast 2022-2027 ($ billion)
- Exhibit 36: Chart on Cancer - Year-over-year growth 2022-2027 (%)
- Exhibit 37: Data Table on Cancer - Year-over-year growth 2022-2027 (%)
- 6.4 Infectious diseases - Market size and forecast 2022-2027
- Exhibit 38: Chart on Infectious diseases - Market size and forecast 2022-2027 ($ billion)
- Exhibit 39: Data Table on Infectious diseases - Market size and forecast 2022-2027 ($ billion)
- Exhibit 40: Chart on Infectious diseases - Year-over-year growth 2022-2027 (%)
- Exhibit 41: Data Table on Infectious diseases - Year-over-year growth 2022-2027 (%)
- 6.5 Autoimmune diseases - Market size and forecast 2022-2027
- Exhibit 42: Chart on Autoimmune diseases - Market size and forecast 2022-2027 ($ billion)
- Exhibit 43: Data Table on Autoimmune diseases - Market size and forecast 2022-2027 ($ billion)
- Exhibit 44: Chart on Autoimmune diseases - Year-over-year growth 2022-2027 (%)
- Exhibit 45: Data Table on Autoimmune diseases - Year-over-year growth 2022-2027 (%)
- 6.6 Others - Market size and forecast 2022-2027
- Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ billion)
- Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
- Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
- Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
- 6.7 Market opportunity by Application
- Exhibit 50: Market opportunity by Application ($ billion)
- Exhibit 51: Data Table on Market opportunity by Application ($ billion)
7 Market Segmentation by Product
- 7.1 Market segments
- Exhibit 52: Chart on Product - Market share 2022-2027 (%)
- Exhibit 53: Data Table on Product - Market share 2022-2027 (%)
- 7.2 Comparison by Product
- Exhibit 54: Chart on Comparison by Product
- Exhibit 55: Data Table on Comparison by Product
- 7.3 Antibody therapeutics - Market size and forecast 2022-2027
- Exhibit 56: Chart on Antibody therapeutics - Market size and forecast 2022-2027 ($ billion)
- Exhibit 57: Data Table on Antibody therapeutics - Market size and forecast 2022-2027 ($ billion)
- Exhibit 58: Chart on Antibody therapeutics - Year-over-year growth 2022-2027 (%)
- Exhibit 59: Data Table on Antibody therapeutics - Year-over-year growth 2022-2027 (%)
- 7.4 Vaccines - Market size and forecast 2022-2027
- Exhibit 60: Chart on Vaccines - Market size and forecast 2022-2027 ($ billion)
- Exhibit 61: Data Table on Vaccines - Market size and forecast 2022-2027 ($ billion)
- Exhibit 62: Chart on Vaccines - Year-over-year growth 2022-2027 (%)
- Exhibit 63: Data Table on Vaccines - Year-over-year growth 2022-2027 (%)
- 7.5 Cell therapy - Market size and forecast 2022-2027
- Exhibit 64: Chart on Cell therapy - Market size and forecast 2022-2027 ($ billion)
- Exhibit 65: Data Table on Cell therapy - Market size and forecast 2022-2027 ($ billion)
- Exhibit 66: Chart on Cell therapy - Year-over-year growth 2022-2027 (%)
- Exhibit 67: Data Table on Cell therapy - Year-over-year growth 2022-2027 (%)
- 7.6 Gene therapy - Market size and forecast 2022-2027
- Exhibit 68: Chart on Gene therapy - Market size and forecast 2022-2027 ($ billion)
- Exhibit 69: Data Table on Gene therapy - Market size and forecast 2022-2027 ($ billion)
- Exhibit 70: Chart on Gene therapy - Year-over-year growth 2022-2027 (%)
- Exhibit 71: Data Table on Gene therapy - Year-over-year growth 2022-2027 (%)
- 7.7 Others - Market size and forecast 2022-2027
- Exhibit 72: Chart on Others - Market size and forecast 2022-2027 ($ billion)
- Exhibit 73: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
- Exhibit 74: Chart on Others - Year-over-year growth 2022-2027 (%)
- Exhibit 75: Data Table on Others - Year-over-year growth 2022-2027 (%)
- 7.8 Market opportunity by Product
- Exhibit 76: Market opportunity by Product ($ billion)
- Exhibit 77: Data Table on Market opportunity by Product ($ billion)
8 Customer Landscape
- 8.1 Customer landscape overview
- Exhibit 78: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
- 9.1 Geographic segmentation
- Exhibit 79: Chart on Market share by geography 2022-2027 (%)
- Exhibit 80: Data Table on Market share by geography 2022-2027 (%)
- 9.2 Geographic comparison
- Exhibit 81: Chart on Geographic comparison
- Exhibit 82: Data Table on Geographic comparison
- 9.3 North America - Market size and forecast 2022-2027
- Exhibit 83: Chart on North America - Market size and forecast 2022-2027 ($ billion)
- Exhibit 84: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
- Exhibit 85: Chart on North America - Year-over-year growth 2022-2027 (%)
- Exhibit 86: Data Table on North America - Year-over-year growth 2022-2027 (%)
- 9.4 Europe - Market size and forecast 2022-2027
- Exhibit 87: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
- Exhibit 88: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
- Exhibit 89: Chart on Europe - Year-over-year growth 2022-2027 (%)
- Exhibit 90: Data Table on Europe - Year-over-year growth 2022-2027 (%)
- 9.5 Asia - Market size and forecast 2022-2027
- Exhibit 91: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
- Exhibit 92: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
- Exhibit 93: Chart on Asia - Year-over-year growth 2022-2027 (%)
- Exhibit 94: Data Table on Asia - Year-over-year growth 2022-2027 (%)
- 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
- Exhibit 95: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
- Exhibit 96: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
- Exhibit 97: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- Exhibit 98: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- 9.7 US - Market size and forecast 2022-2027
- Exhibit 99: Chart on US - Market size and forecast 2022-2027 ($ billion)
- Exhibit 100: Data Table on US - Market size and forecast 2022-2027 ($ billion)
- Exhibit 101: Chart on US - Year-over-year growth 2022-2027 (%)
- Exhibit 102: Data Table on US - Year-over-year growth 2022-2027 (%)
- 9.8 China - Market size and forecast 2022-2027
- Exhibit 103: Chart on China - Market size and forecast 2022-2027 ($ billion)
- Exhibit 104: Data Table on China - Market size and forecast 2022-2027 ($ billion)
- Exhibit 105: Chart on China - Year-over-year growth 2022-2027 (%)
- Exhibit 106: Data Table on China - Year-over-year growth 2022-2027 (%)
- 9.9 Germany - Market size and forecast 2022-2027
- Exhibit 107: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
- Exhibit 108: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
- Exhibit 109: Chart on Germany - Year-over-year growth 2022-2027 (%)
- Exhibit 110: Data Table on Germany - Year-over-year growth 2022-2027 (%)
- 9.10 France - Market size and forecast 2022-2027
- Exhibit 111: Chart on France - Market size and forecast 2022-2027 ($ billion)
- Exhibit 112: Data Table on France - Market size and forecast 2022-2027 ($ billion)
- Exhibit 113: Chart on France - Year-over-year growth 2022-2027 (%)
- Exhibit 114: Data Table on France - Year-over-year growth 2022-2027 (%)
- 9.11 Japan - Market size and forecast 2022-2027
- Exhibit 115: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
- Exhibit 116: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
- Exhibit 117: Chart on Japan - Year-over-year growth 2022-2027 (%)
- Exhibit 118: Data Table on Japan - Year-over-year growth 2022-2027 (%)
- 9.12 Market opportunity by geography
- Exhibit 119: Market opportunity by geography ($ billion)
- Exhibit 120: Data Tables on Market opportunity by geography ($ billion)
10 Drivers, Challenges, and Trends
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- Exhibit 121: Impact of drivers and challenges in 2022 and 2027
- 10.4 Market trends
11 Vendor Landscape
- 11.1 Overview
- 11.2 Vendor landscape
- Exhibit 122: Overview on Criticality of inputs and Factors of differentiation
- 11.3 Landscape disruption
- Exhibit 123: Overview on factors of disruption
- 11.4 Industry risks
- Exhibit 124: Impact of key risks on business
12 Vendor Analysis
- 12.1 Vendors covered
- Exhibit 125: Vendors covered
- 12.2 Market positioning of vendors
- Exhibit 126: Matrix on vendor position and classification
- 12.3 AbbVie Inc.
- Exhibit 127: AbbVie Inc. - Overview
- Exhibit 128: AbbVie Inc. - Product / Service
- Exhibit 129: AbbVie Inc. - Key news
- Exhibit 130: AbbVie Inc. - Key offerings
- 12.4 Amgen Inc.
- Exhibit 131: Amgen Inc. - Overview
- Exhibit 132: Amgen Inc. - Product / Service
- Exhibit 133: Amgen Inc. - Key offerings
- 12.5 AstraZeneca Plc
- Exhibit 134: AstraZeneca Plc - Overview
- Exhibit 135: AstraZeneca Plc - Product / Service
- Exhibit 136: AstraZeneca Plc - Key news
- Exhibit 137: AstraZeneca Plc - Key offerings
- 12.6 Aurobindo Pharma Ltd.
- Exhibit 138: Aurobindo Pharma Ltd. - Overview
- Exhibit 139: Aurobindo Pharma Ltd. - Product / Service
- Exhibit 140: Aurobindo Pharma Ltd. - Key offerings
- 12.7 Baxter International Inc.
- Exhibit 141: Baxter International Inc. - Overview
- Exhibit 142: Baxter International Inc. - Business segments
- Exhibit 143: Baxter International Inc. - Key news
- Exhibit 144: Baxter International Inc. - Key offerings
- Exhibit 145: Baxter International Inc. - Segment focus
- 12.8 Biocon Ltd.
- Exhibit 146: Biocon Ltd. - Overview
- Exhibit 147: Biocon Ltd. - Business segments
- Exhibit 148: Biocon Ltd. - Key offerings
- Exhibit 149: Biocon Ltd. - Segment focus
- 12.9 Celltrion Healthcare Co. Ltd.
- Exhibit 150: Celltrion Healthcare Co. Ltd. - Overview
- Exhibit 151: Celltrion Healthcare Co. Ltd. - Product / Service
- Exhibit 152: Celltrion Healthcare Co. Ltd. - Key offerings
- 12.10 Eli Lilly and Co.
- Exhibit 153: Eli Lilly and Co. - Overview
- Exhibit 154: Eli Lilly and Co. - Product / Service
- Exhibit 155: Eli Lilly and Co. - Key offerings
- 12.11 GlaxoSmithKline Plc
- Exhibit 156: GlaxoSmithKline Plc - Overview
- Exhibit 157: GlaxoSmithKline Plc - Business segments
- Exhibit 158: GlaxoSmithKline Plc - Key news
- Exhibit 159: GlaxoSmithKline Plc - Key offerings
- Exhibit 160: GlaxoSmithKline Plc - Segment focus
- 12.12 Merck and Co. Inc.
- Exhibit 161: Merck and Co. Inc. - Overview
- Exhibit 162: Merck and Co. Inc. - Business segments
- Exhibit 163: Merck and Co. Inc. - Key news
- Exhibit 164: Merck and Co. Inc. - Key offerings
- Exhibit 165: Merck and Co. Inc. - Segment focus
- 12.13 Novartis AG
- Exhibit 166: Novartis AG - Overview
- Exhibit 167: Novartis AG - Business segments
- Exhibit 168: Novartis AG - Key offerings
- Exhibit 169: Novartis AG - Segment focus
- 12.14 Pfizer Inc.
- Exhibit 170: Pfizer Inc. - Overview
- Exhibit 171: Pfizer Inc. - Product / Service
- Exhibit 172: Pfizer Inc. - Key news
- Exhibit 173: Pfizer Inc. - Key offerings
- 12.15 Precision Biologics Inc.
- Exhibit 174: Precision Biologics Inc. - Overview
- Exhibit 175: Precision Biologics Inc. - Product / Service
- Exhibit 176: Precision Biologics Inc. - Key offerings
- 12.16 Samsung Electronics Co. Ltd.
- Exhibit 177: Samsung Electronics Co. Ltd. - Overview
- Exhibit 178: Samsung Electronics Co. Ltd. - Business segments
- Exhibit 179: Samsung Electronics Co. Ltd. - Key news
- Exhibit 180: Samsung Electronics Co. Ltd. - Key offerings
- Exhibit 181: Samsung Electronics Co. Ltd. - Segment focus
- 12.17 Sanofi SA
- Exhibit 182: Sanofi SA - Overview
- Exhibit 183: Sanofi SA - Business segments
- Exhibit 184: Sanofi SA - Key news
- Exhibit 185: Sanofi SA - Key offerings
- Exhibit 186: Sanofi SA - Segment focus
13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- Exhibit 187: Inclusions checklist
- Exhibit 188: Exclusions checklist
- 13.3 Currency conversion rates for US$
- Exhibit 189: Currency conversion rates for US$
- 13.4 Research methodology
- Exhibit 190: Research methodology
- Exhibit 191: Validation techniques employed for market sizing
- Exhibit 192: Information sources
- 13.5 List of abbreviations
- Exhibit 193: List of abbreviations
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases
DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts
REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
PURCHASE FULL REPORT OF
biologic therapeutics market
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
- Off-the-shelf research reports
- Reports can be tailored to meet the customer's needs
- Trusted by more than 100 fortune 500 organizations
- Information about the market's key drivers, trends, and challenges
- Parent market analysis
- Every week, 50,000 people visit our subscription platform
- Detailed vendors report with competitive landscape
- Covid-19 impact and recovery analysis
- Data on revenue-generating market segments
- Details on the market shares of various regions
- Five-force market analysis